Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation

Anna Drosou, Robert S. Kirsner, Tomoaki Kato, Naveen K Mittal, Ahmed Al-Niami, Barbara Miller, Andreas G. Tzakis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Primary wound closure is not always possible after pediatric multi-visceral transplantation because of oversized donor organs and/or intestinal or graft edema. We report our experience evaluating the safety and efficacy of Graftskin (Apligraf, Organogenesis, Canton, Mass), a bioengineered bi-layered human skin equivalent, for the management of difficult skin abdominal defects after multivisceral transplantation in a pediatric population. Methods: A retrospective chart review was performed of pediatric multivisceral transplantation patients who were treated with Graftskin. Adverse events, course of wound reepithelialization, and time for complete closure were recorded. Results: Four patients, 7 to 29 months old, were treated with Graftskin. One patient died because of unrelated reasons. Stimulation of the granulation, reepithelialization, and rapid reduction of the wound surface and depth occurred in the other 3 patients. Complete reepithelialization occurred within 5 months. No adverse events were noted. Conclusion: Graftskin was a successful treatment for difficult abdominal skin defects after liver and multivisceral transplantation in children.

Original languageEnglish (US)
Pages (from-to)854-858
Number of pages5
JournalJournal of the American Academy of Dermatology
Volume52
Issue number5
DOIs
StatePublished - May 2005
Externally publishedYes

Fingerprint

Transplantation
Pediatrics
Skin
Wounds and Injuries
Organogenesis
Liver Transplantation
Edema
Tissue Donors
Transplants
Safety
Population
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation. / Drosou, Anna; Kirsner, Robert S.; Kato, Tomoaki; Mittal, Naveen K; Al-Niami, Ahmed; Miller, Barbara; Tzakis, Andreas G.

In: Journal of the American Academy of Dermatology, Vol. 52, No. 5, 05.2005, p. 854-858.

Research output: Contribution to journalArticle

Drosou, Anna ; Kirsner, Robert S. ; Kato, Tomoaki ; Mittal, Naveen K ; Al-Niami, Ahmed ; Miller, Barbara ; Tzakis, Andreas G. / Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation. In: Journal of the American Academy of Dermatology. 2005 ; Vol. 52, No. 5. pp. 854-858.
@article{923c5b86174e494cab6dbf94bdf18648,
title = "Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation",
abstract = "Background: Primary wound closure is not always possible after pediatric multi-visceral transplantation because of oversized donor organs and/or intestinal or graft edema. We report our experience evaluating the safety and efficacy of Graftskin (Apligraf, Organogenesis, Canton, Mass), a bioengineered bi-layered human skin equivalent, for the management of difficult skin abdominal defects after multivisceral transplantation in a pediatric population. Methods: A retrospective chart review was performed of pediatric multivisceral transplantation patients who were treated with Graftskin. Adverse events, course of wound reepithelialization, and time for complete closure were recorded. Results: Four patients, 7 to 29 months old, were treated with Graftskin. One patient died because of unrelated reasons. Stimulation of the granulation, reepithelialization, and rapid reduction of the wound surface and depth occurred in the other 3 patients. Complete reepithelialization occurred within 5 months. No adverse events were noted. Conclusion: Graftskin was a successful treatment for difficult abdominal skin defects after liver and multivisceral transplantation in children.",
author = "Anna Drosou and Kirsner, {Robert S.} and Tomoaki Kato and Mittal, {Naveen K} and Ahmed Al-Niami and Barbara Miller and Tzakis, {Andreas G.}",
year = "2005",
month = "5",
doi = "10.1016/j.jaad.2004.11.069",
language = "English (US)",
volume = "52",
pages = "854--858",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation

AU - Drosou, Anna

AU - Kirsner, Robert S.

AU - Kato, Tomoaki

AU - Mittal, Naveen K

AU - Al-Niami, Ahmed

AU - Miller, Barbara

AU - Tzakis, Andreas G.

PY - 2005/5

Y1 - 2005/5

N2 - Background: Primary wound closure is not always possible after pediatric multi-visceral transplantation because of oversized donor organs and/or intestinal or graft edema. We report our experience evaluating the safety and efficacy of Graftskin (Apligraf, Organogenesis, Canton, Mass), a bioengineered bi-layered human skin equivalent, for the management of difficult skin abdominal defects after multivisceral transplantation in a pediatric population. Methods: A retrospective chart review was performed of pediatric multivisceral transplantation patients who were treated with Graftskin. Adverse events, course of wound reepithelialization, and time for complete closure were recorded. Results: Four patients, 7 to 29 months old, were treated with Graftskin. One patient died because of unrelated reasons. Stimulation of the granulation, reepithelialization, and rapid reduction of the wound surface and depth occurred in the other 3 patients. Complete reepithelialization occurred within 5 months. No adverse events were noted. Conclusion: Graftskin was a successful treatment for difficult abdominal skin defects after liver and multivisceral transplantation in children.

AB - Background: Primary wound closure is not always possible after pediatric multi-visceral transplantation because of oversized donor organs and/or intestinal or graft edema. We report our experience evaluating the safety and efficacy of Graftskin (Apligraf, Organogenesis, Canton, Mass), a bioengineered bi-layered human skin equivalent, for the management of difficult skin abdominal defects after multivisceral transplantation in a pediatric population. Methods: A retrospective chart review was performed of pediatric multivisceral transplantation patients who were treated with Graftskin. Adverse events, course of wound reepithelialization, and time for complete closure were recorded. Results: Four patients, 7 to 29 months old, were treated with Graftskin. One patient died because of unrelated reasons. Stimulation of the granulation, reepithelialization, and rapid reduction of the wound surface and depth occurred in the other 3 patients. Complete reepithelialization occurred within 5 months. No adverse events were noted. Conclusion: Graftskin was a successful treatment for difficult abdominal skin defects after liver and multivisceral transplantation in children.

UR - http://www.scopus.com/inward/record.url?scp=18144419686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144419686&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2004.11.069

DO - 10.1016/j.jaad.2004.11.069

M3 - Article

C2 - 15858477

AN - SCOPUS:18144419686

VL - 52

SP - 854

EP - 858

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 5

ER -